Introduction
There has been a dramatic decline in the prevalence of syphilis in Southern and Eastern Africa over the past two decades. In South Africa, for example, the prevalence dropped from 10.8% to 1.6% between 1998 and 2004 among women attending antenatal care. 1 Two explanations for this have dominated the literature. Authors of a paper entitled ''Declining syphilis prevalence among pregnant women in northern Botswana: an encouraging sign for the HIV epidemic?'' argued that reductions in higher-risk sex and the introduction of syndromic management of sexually transmitted infections (STIs) were responsible. 2 Similar explanations were offered in an analysis of factors responsible for the decline in syphilis prevalence among pregnant women in Nairobi since 1995. 3 In contrast, a study from the USA that applied regression analysis to state-level AIDS mortality rates and syphilis incidence rates found that AIDS mortality explained one-third to one-half of the decline in syphilis incidence among men. 4 This can be explained by the strong association between HIV and syphilis at the individual-level, and that people at risk for syphilis are also at increased risk for HIV infection. In the era preceding the availability of antiretroviral therapy (ART), a relatively high proportion of individuals contributing to syphilis transmission would have been co-infected with HIV and subsequently died from AIDS. Although estimates of syphilis and HIV co-infection were not routinely reported, AIDS mortality could have been responsible for reducing a substantial portion of syphilis transmission and overall syphilis prevalence. Mathematical modelling of data from South Africa suggests that increased condom usage, improved treatment of STIs, and AIDS mortality were collectively responsible for the decline in syphilis prevalence between 1990 and 2005. 5 From a public health perspective, it is important to establish which of these three factors may have produced the greatest reductions in syphilis prevalence in Southern and Eastern Africa. If International Journal of Infectious Diseases 29 (2014) [54] [55] [56] [57] [58] [59] [60] [61] improved STI treatment and behaviour change had the greatest impact, then recent suggestions are plausible that syphilis prevalence should remain low in future years and that syphilis is a reasonable candidate for elimination in the region. 6 However, if AIDS mortality played a key role in reducing the population prevalence of syphilis, then the comparatively recent and widespread implementation of ART in the region may lead to a concomitant resurgence of syphilis. Since HIV has become a chronic disease that is manageable by ART in high-income countries, syphilis incidence has increased sharply, particularly among men who have sex with men. 7 This has been due to a number of factors including reduced AIDS mortality, behavioural disinhibition, and other factors. 8, 9 We used ecological regression analyses to test the hypothesis that AIDS mortality was an important driver of the decline in syphilis prevalence in Southern and Eastern Africa. Underlying our methodology is the hypothesis that if AIDS mortality has contributed to reductions, then areas with a higher peak-HIV prevalence should have experienced a more rapid and profound decline in syphilis incidence and prevalence than otherwise might have occurred. Thus, we compare the association between syphilis and HIV prevalence at a national level before and after the period of peak-HIV prevalence.
Methods

Syphilis prevalence data
National syphilis prevalence estimates were taken from sources as detailed in Table 1 . We used national antenatal surveys wherever possible. However, to our knowledge there are no national antenatal survey data available for a number of countries, particularly from the early years of the HIV epidemic. In these cases, we drew data from antenatal surveys conducted from geographic regions within countries that had mainly been identified in two systematic reviews. One was a systematic review of the prevalence of malaria and curable STIs among pregnant women attending antenatal care in Sub-Saharan Africa between 1990 and 2011; 10 this review excluded South Africa where malaria is no longer endemic. The other was a systematic review of STI prevalence in South Africa between 1985 and 2003 in selected sentinel populations. 11 We only used prevalence estimates from antenatal surveys in these systematic reviews. Antenatal data from additional sources were drawn from Botswana, Lesotho, Kenya, Malawi, and Tanzania. Further details for all sources are provided in Table 1 . In addition, prevalence estimates were taken from several nationally representative surveys conducted in Uganda (2005 and 2011) 12, 13 and Madagascar (2003). 14 These surveys provided syphilis prevalence estimates among 15-49-year-old women. Syphilis prevalence data from earlier in Uganda's HIV epidemic were obtained from two studies. 15, 16 Because the first of these two studies (1993 estimates) reported combined estimates for men and women, these were only used for the graphical representation of syphilis prevalence over time in Uganda and not in the calculation of syphilis prevalence from before the peak-HIV prevalence. The second study (1998 estimate) employed a population-based sampling strategy; these estimates for women were used as the pre-peak HIV syphilis prevalence.
A number of prevalence estimates were obtained from the World Health Organization's Global Data Repository, which has been an important source of national antenatal syphilis prevalence estimates since 2008. 17 Insufficient data were found for Burundi, Rwanda, and Swaziland to warrant their inclusion in our study. In total, data from 11 countries were used to calculate the following variables: (1) 'Peak-HIV prevalence' defined as the highest HIV prevalence in the relevant area (country or province) between 1990 and 2009. The utility of peak HIV prevalence as a means of comparing different HIV epidemics has been detailed elsewhere. 18, 19 (2) 'Pre-peak-HIV syphilis prevalence' defined as the syphilis prevalence in the country from the first year this was measured. (3) 'Post-peak-HIV syphilis prevalence' defined as the nadir of syphilis prevalence reached in the period after the year that HIV prevalence reached its peak prevalence. (4) 'Change in syphilis prevalence' defined as the absolute difference (in percentage terms) between the mean syphilis prevalence in the period before the year that HIV reached its peak prevalence in that country and the mean syphilis prevalence in the post-peak-HIV period.
HIV prevalence data
We obtained country-and year-specific 15-49-year-old HIV prevalence estimates from UNAIDS for the period 1990-2010 (http://www.unaids.org/en/dataanalysis/knowyourepidemic).
Statistical analyses
We performed linear regression to analyze the relationship between syphilis prevalence and peak-HIV prevalence, and applied Pearson's correlation coefficient (R 2 ) to measure the proportion of explainable variance. Analyses were performed using Stata 12.1 (StataCorp LP, College Station, TX, USA).
Results
As shown in Figure 1 , the only country not to experience a drop in syphilis prevalence during this time period was Madagascar, which was also the only country in Southern and Eastern Africa without a generalized HIV epidemic. The other 10 countries of our analysis experienced a decline in syphilis that occurred at some point after the onset of the HIV epidemic in the country. In one-half of these countries, syphilis prevalence declined within 10 years of HIV prevalence reaching 1% (Botswana, Lesotho, Kenya, Malawi, and South Africa), whereas in the remaining countries, syphilis declined some time later (Mozambique, Tanzania, Uganda, Zambia, and Zimbabwe).
There was a strong positive association between the syphilis prevalence (pre-peak-HIV) and the peak-HIV prevalence at a country level (R 2 = 0.59; p = 0.006; see Figure 2a ). Although only of borderline statistical significance, the linear relationship between HIV prevalence and syphilis prevalence switched to a negative direction when peak-HIV prevalence was related to post-peak-HIV syphilis prevalence (R 2 = 0.32; p = 0.07; Figure 2b ). There was also a statistically significant positive association between peak-HIV prevalence and the change in syphilis prevalence (R 2 = 0.85; p = 0.0001; Figure 2c ).
Discussion
The syndromic management of STIs was introduced into all countries of Southern and Eastern Africa in the late 1990s. There is no evidence we could find that the method was less effectively implemented in Madagascar than elsewhere. 20 Madagascar is the only country in the region not to have experienced a generalized HIV epidemic or a decline in syphilis prevalence. One possible explanation is that AIDS mortality played an important role in the decline in syphilis prevalence rates. This is also a plausible interpretation for the observed shift in the relationship between syphilis and HIV prevalence at the country level, from a positive association early in the HIV epidemic to a negative association late in the HIV epidemic. This suggests that countries with higher peak HIV prevalence rates had greater declines in syphilis prevalence. As observed in the USA, AIDS mortality could have been responsible for this effect in Southern and Eastern Africa. The effect of AIDS mortality could have been mediated via three pathways: (1) individuals most at risk of syphilis acquisition and transmission were removed from the population; (2) people living in areas with higher AIDS mortality may have been more likely to change their sexual behaviour; 4,21 and (3) depletion of the pool of high-risk persons might have made it difficult for the remaining high-risk persons to find sufficient partners with whom to engage in risky sex. 22 Another potential interpretation of our findings is that optimal STI treatment was more effectively provided in countries with higher peak HIV prevalence estimates. However, an analysis using a number of data sources as proxy measures for the efficacy of STI treatment showed there to be no relationship between peak-HIV prevalence and STI treatment efficacy. 23 Alternatively, it is possible that countries more heavily affected by HIV also responded more rapidly to the epidemic, thereby accelerating reductions in higherrisk sex within their borders. However, we could find scant evidence to support this theory. Analysis of changes in risk behaviour in South Africa's ethnic groups, for example, suggests that ethnic groups most affected by HIV also showed a more rapid increase in condom usage, but this did not translate into lower HIV prevalence because there was little change in their rates of multiple and concurrent partnering, which remained considerably higher than among groups with a low prevalence of HIV. 24 Thirdly, the declines in syphilis prevalence may be due to some other unmeasured variable. The reasons behind the declines in syphilis prevalence are likely to be multifactorial and to vary somewhat among countries. This may explain the finding that in some countries syphilis prevalence declined relatively soon after the HIV epidemic began whereas in others it declined some time later.
There are a number of limitations with this analysis. The main problem is the paucity of accurate representative syphilis prevalence data. This is particularly the case in the 1980s and 1990s. We were thus forced in a number of instances to use data that were derived from local surveys that are unlikely to reflect national populations. Thus, our country-level findings of a positive relationship between peak-HIV prevalence and pre-peak-HIV syphilis prevalence should be interpreted with caution. However, it should be noted that syphilis prevalence estimates from surveys conducted prior to the peak of HIV were all high (4%) and considerably lower following the peak-HIV period. This is in keeping with the findings of the systematic review of curable STIs among pregnant women attending antenatal care facilities in Sub-Saharan Africa and the World Health Organization reports on this topic. 10, 25, 26 Since HIV is one of a number of causes of a false-positive diagnosis using rapid plasma reagin (RPR) assays, the HIV epidemic could have influenced RPR-based estimates of syphilis prevalence. 27 However, the fact that the syphilis prevalence dropped rather than rose as HIV prevalence increased suggests that this was unlikely to have played a large role. RPR results can also vary by a one-dilution titre between different batches, which adds a further potential misclassification bias. 28 The endemic treponematosesyaws, bejel, and pinta -are other possible causes of false-positives with all the testing algorithms used in the studies. Thus, observed declines in syphilis prevalence may have been an artefact of reductions in these other treponematoses. This is however most unlikely, as none of the countries investigated here had reported any of these diseases between 1980 and 2012. 29 A further reason we do not believe our results are a chance finding is that we have found the same association between syphilis and peak-HIV prevalence at a provincial level in South Africa and Zambia and at a district council level in South Africa. In each of these studies we found the same positive relationship between syphilis prevalence early in the HIV epidemic and peak-HIV epidemic and a negative relationship between syphilis prevalence late in the HIV epidemic and peak-HIV prevalence (C. Kenyon; unpublished results). There has been a commendable reduction in syphilis prevalence in almost all the countries in this region. The data presented here, however, add to evidence from elsewhere that AIDS mortality likely played a significant role in this decline. The widespread availability of ART in high-income countries has indirectly contributed to a resurgence of syphilis in such settings through a combination of reduced AIDS mortality and behavioural disinhibition. 30 Both of these factors have been noted in Southern and Eastern Africa. 31, 32 Vigilant surveillance is therefore necessary to detect a potential re-emergence of syphilis prevalence, as observed in high-income countries, and to render a timely public health response.
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